CClinicalTrials.gg
CompletedNCT06468878Updated Jun 25, 2026

Virtual Reality Intervention for Fear of Heights

An interventional study of Exposure Intervention Plus Music Induction and Exposure Intervention With No Music Induction in Acrophobia, sponsored by Boston University Charles River Campus. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Exposure-based cognitive behavior therapy is an efficacious treatment for acrophobia (fear of heights) and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate the effects of liked, non-lyrical background music on the efficacy of a brief VR exposure intervention.

Read the detailed description

The goal of this clinical trial is to compare acrophobia (fear of heights) outcomes for VR exposure therapy in college students with elevated acrophobia when listening to music during exposure versus no music. The overarching aim of the current study is to determine how liked, non-lyrical background music will influence acrophobia outcomes after a brief exposure therapy session in VR.

The study involves three phases: (1) initial screening, (2) in-person assessment and a brief exposure intervention for a subset of participants with elevated acrophobia, and (3) a one-week follow-up assessment conducted online. Students who choose to participate and screen high on an acrophobia scale will be assigned to an experimental or control condition prior to undergoing VR based exposure therapy. Acrophobia outcomes are measured immediately post-intervention and one week later.

Researchers will compare participants in the music condition to participants in the non-music condition to see if acrophobia outcomes differ.

02

Conditions studied

  • Acrophobia
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Self-report of 18 years of age or older
  • Current student at Boston University
  • Ability to read English to provide informed consent
  • Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet)
  • For Phase 2: Acrophobia score of ≥ 45.45 on the Acrophobia Questionnaire (AQ) Anxiety Subscale

Exclusion criteria

Exclusion Criteria:

  • Previous participation (i.e. no participant may take the survey more than once).
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Exposure Intervention with Non-Lyrical, Liked Background Music

    Participants will be presented with a list of instrumental songs without lyrics from popular movies. Participants will then rank the songs in order of those they would like to hear the most. During VR heights exposure the participants' highest-ranked songs will be played in the background at a low volume.

    Behavioral: Exposure Intervention Plus Music Induction

  • Experimental
    Exposure Intervention without Background Music

    Participants will undergo VR heights exposure without background music.

    Behavioral: Exposure Intervention With No Music Induction

Interventions

  • BehavioralExposure Intervention Plus Music Induction

    VR exposure for acrophobia with background music.

  • BehavioralExposure Intervention With No Music Induction

    VR exposure for acrophobia with no background music.

05

What researchers measure

Primary outcomes

  1. Acrophobia (Fear of Heights)

    Assessed using the Acrophobia Questionnaire (AQ) Anxiety Subscale

    Time frame: Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure

Secondary outcomes

  1. Valance

    Self-report measure of how participant feels about experiencing high-height environments.

    Time frame: Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure

  2. Height-Relevant Interpretations

    Assessed using the Heights Interpretation Questionnaire (HIQ)

    Time frame: Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure

06

Study locations

1 site
  • Boston University
    Boston, Massachusetts 02215, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06468878
Lead sponsor
Boston University Charles River Campus
Responsible party
Sponsor
First posted
Jun 21, 2024
Start date
Jul 8, 2024
Primary completion
Dec 1, 2025
Completion
Dec 1, 2025
Last update
Jun 25, 2026

Study contacts

Laura Long, PhD
principal investigator · Boston University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion